Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2021-09-13 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
第三届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the third Supervisory Board of the company. It includes details about the meeting attendance, election of the Supervisory Board chairman, and appointment of the internal audit head. There is no financial data, no mention of annual or interim reports, no earnings information, and no regulatory certifications. The content is about board-level decisions and appointments related to governance and internal audit functions. This fits best under Board/Management Information (MANG), which covers announcements of changes in company board or senior management positions.
2021-09-13 Chinese
关于内蒙古博斯泰企业管理服务有限公司完成工商变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a business registration change following the acquisition of a 51% stake in a company, making it a controlling subsidiary. It includes details about the company name, registration code, legal representative, capital, and business scope. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is a regulatory announcement about a corporate event (business registration change) related to a capital acquisition. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like M&A filings or capital changes explicitly. The document length is short and focused on the announcement of the completion of the registration change, not a full report or detailed financial disclosure.
2021-09-03 Chinese
关于参加独立董事培训并取得独立董事资格证书的承诺书-冯岚
Regulatory Filings Classification · 95% confidence The document is a commitment letter from an independent director candidate stating their intention to attend training and obtain a qualification certificate as required by regulatory guidelines. It does not contain financial data, report content, or announcements of financial results. It is a regulatory compliance statement related to director qualifications, which does not fit into financial report categories. Therefore, it is best classified under Regulatory Filings (RNS) as a compliance document.
2021-08-25 Chinese
独立董事提名人声明1
Board/Management Information Classification · 95% confidence The document is a formal statement from a nominator (the company's board) regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. The content is focused on board/management information, specifically about a director nomination. There is no financial data, earnings information, or report publication mentioned. The document is not an announcement of voting results or a proxy solicitation but a nomination statement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (5738 characters) supports it being a full statement rather than a brief announcement.
2021-08-25 Chinese
公司章程（2021年8月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 西藏易明西雅医药科技股份有限公司, dated August 2021. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and procedures for shareholder meetings. The content is a comprehensive governance document outlining the internal rules, board structure, shareholder meeting procedures, and company management. It is not a financial report, earnings release, or announcement but a governance framework document. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2021-08-25 Chinese
关于募集资金2021年半年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage and usage of funds raised by the company during the half-year period ending June 30, 2021. It includes specifics about the amount of funds raised, their allocation, changes in investment projects, compliance with regulatory requirements, and approvals by the board. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and it is titled as a "专项报告" (special report) on the use of raised funds for the 2021 half-year period. It contains substantive financial data and analysis related to capital raised and its deployment, not just an announcement or certification. This matches the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an Annual Report, Interim Report, or Earnings Release, as it focuses specifically on the use of raised funds rather than overall financial performance. It is also not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains detailed financial data and is not merely an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2021-08-25 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.